RAV12
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RAV12, covering 2012-12-19 to 2012-12-19. Get the full timeline:
Most recent: Clinical Trial Update: Monoclonal Antibody RAV12 and Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer [Phase 2]